Cameco 2Q26 Review: Potential Westinghouse IPO Enhances Long-Term Value Visibility

Overview

This report reviews Bernstein's assessment of Cameco's 2Q26 results. The report believes near-term model changes are limited, so the target price remains unchanged; however, long-term model value and clarity have improved, with the key incremental drivers being expanded disclosures on the Westinghouse business and an accelerated potential IPO process.

Core views

The core view is that Cameco's long-term investment thesis is expanding from a single uranium-price exposure into a combination of "uranium price upside + a re-rating of Westinghouse's nuclear equipment and services value." Westinghouse's existing reactor designs have construction and delivery track records, and management expects the company to secure approximately one-third of the global new nuclear construction market by 2040. Meanwhile, global long-term uranium prices are near their highest levels in more than a decade, supporting Cameco's earnings leverage.

Analysis framework

The report analyzes 2Q26 results, the target price model, Westinghouse business disclosures, the economics of new nuclear projects, uranium contract price trends, and disclosed risks. For valuation, Bernstein rolls the valuation year forward to 2030E EBITDA to better reflect the earnings inflection point and Cameco's exposure to long-term uranium prices, while incorporating updated assumptions on Westinghouse economics.

Methodology notes

• Relative valuationEV/EBITDA multiple valuation

  Apply a 23x EV/EBITDA multiple to 2030E EBITDA

  Bernstein values Cameco using 2030E EBITDA of CAD 3.2bln and a 23x EV/EBITDA multiple, incorporates additional shareholder returns, and derives a USD 135/sh target price.

• Absolute valuationDCF

  Discounting Westinghouse project value

  The report notes that in the detailed DCF, Westinghouse contributes approximately 50% of value in both the base-case and bull-case scenarios; even under conservative base assumptions, the shares still offer upside relative to the current price.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• CCJ.US

  Covered security

  Strengths

  High uranium prices, improving long-term Westinghouse value, potential IPO-driven re-rating, an Outperform rating, and significant upside to the target price.

  Weaknesses

  Near-term model changes are limited, and the share price performance after the results was mixed and volatile; nuclear project construction costs and timelines still require validation.

  Comparison

  AP1000 costs in the US and globally remain significantly higher than comparable nuclear construction costs in China, but the construction timeline target is substantially better than that of Vogtle 3/4.

  Risks

  Nuclear safety concerns, skilled labor costs, alternative nuclear fuel technologies, and insufficient operational transparency in the Inkai and Kazatoprom partnership.

• CCO.CT

  Canadian-listed line of the same company

  Strengths

  Shares Cameco's fundamentals and the Westinghouse value re-rating thesis with CCJ, with a CAD 189/sh target price.

  Weaknesses

  The share price and target price are affected by exchange rates; the report notes that the CCO share price moved slightly due to FX.

  Comparison

  Relative to CCJ.US, the Canadian line is denominated in CAD, with a target price and current price of CAD 189/sh and CAD 120.98, respectively.

  Risks

  Same as CCJ.US, with additional exposure to exchange-rate fluctuations.

Key data

• RatingOutperformBernstein maintains its Outperform rating on Cameco.
• Target priceUSD 135/sh; CAD 189/shThe target price is based on 2030E EBITDA and a 23x EV/EBITDA multiple.
• Current priceUSD 86.38; CAD 120.98The table uses the closing price as of 2026-07-31.
• 2030E EBITDACAD 3.2blnThe core earnings benchmark used for valuation.
• Westinghouse new-build market share targetApproximately 1/3Management expects Westinghouse to secure approximately one-third of the global new nuclear construction market by 2040.
• Westinghouse project pipelineApproximately 90 to 91 reactor unitsMost commercial operating dates are concentrated in the late 2030s.
• AP1000 overnight cost assumptionUSD 7-8.5bln/unit globally; USD 6-8bln/unit in the USEquivalent to approximately USD 6,100-7,400/kw, above comparable projects in China at approximately USD 2,300-2,600/kw.
• Construction timeline target5-6 years, potentially compressing to approximately 4 years over the long termFrom first nuclear concrete pour to commercial operation, significantly better than the approximately 12 years for Vogtle 3/4.
• Long-term uranium price backdropApproaching USD 100/lbThe report describes this as a more-than-decade high, supported by low contracting levels and demand surprises.
• Westinghouse installed-base coverageOPS covers 63% of approximately 417 operating reactors globally; fuel services approximately 40%The installed reactor base provides a recurring business foundation.

Impact & implications

If the Westinghouse IPO progresses smoothly and achieves greater transparency, the market may more clearly recognize the value of Cameco's nuclear equipment, services, and new-build projects beyond its uranium resources. Sustained high uranium prices would further enhance Cameco's earnings leverage; however, nuclear construction timelines, cost control, labor supply, and regulatory or safety events remain important variables affecting valuation realization.

Risks

• Nuclear safety incidents or public concerns could delay licensing and construction, slow nuclear adoption, and suppress uranium demand.
• The supply of highly skilled labor in the nuclear industry is limited, which could raise wages, compress margins, and disrupt production during shortages or strikes.
• Faster development of plutonium and thorium use in fast reactors or molten-salt reactors could weaken uranium demand, although the report believes these technologies remain at an early stage and Cameco's Asian exposure is limited.
• Operational inconsistency or insufficient transparency in the Inkai project's partnership with Kazatoprom could result in efficiency losses, additional costs, and partnership disputes.
• Westinghouse's new-build market share, AP1000 costs, and construction timeline targets require validation through actual orders, financing, and engineering execution.

What to watch

• The IPO timeline, valuation, and scope of disclosures following Westinghouse's confidential S-1 filing.
• Westinghouse AP1000 orders, conversion progress for the approximately 90-reactor pipeline, and scheduled commercial operating dates.
• Long-term uranium contract prices, whether spot prices remain near USD 100/lb, and the pace of utility contracting.
• Cost trends for AP300 and SMR projects, particularly whether their per-kilowatt costs remain materially higher than those of AP1000.
• Changes in Cameco's subsequent realized prices, cash costs, Westinghouse economics, and 2030E EBITDA assumptions.